N. Chiang

发表

A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodies

D. Seshasayee, Jack Bevers, G. Nakamura, 2018, Scientific Reports.

Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.

L. Presta, G. Nakamura, Yanmei Lu, 2011, Journal of immunological methods.

Cutting Edge: Novel Human Dendritic Cell- and Monocyte-Attracting Chemokine-Like Protein Identified by Fold Recognition Methods

G. Frantz, N. Skelton, K. Schmidt, 2006, The Journal of Immunology.

Monoclonal antibody targeting the β-barrel assembly machine of Escherichia coli is bactericidal

D. Seshasayee, G. Nakamura, J. Payandeh, 2018, Proceedings of the National Academy of Sciences.

Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab

G. Nakamura, A. Rohou, C. Arthur, 2020, Science.

Epitope Location on Tissue Factor Determines the Anticoagulant Potency of Monoclonal Anti-tissue Factor Antibodies

R. Kelley, D. Kirchhofer, C. Eigenbrot, 2000, Thrombosis and Haemostasis.

A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action

Z. Modrušan, G. Nakamura, J. Stinson, 2017, Nature Communications.

Massive antibody discovery used to probe structure–function relationships of the essential outer membrane protein LptD

D. Seshasayee, Jack Bevers, G. Nakamura, 2019, eLife.

Activation of TNF‐R1 receptor in the presence of copper kills TNF resistant CEM leukemic T cells

H. Sussman, B. Fendly, N. Chiang, 1994, Journal of cellular physiology.

Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12

M. Ultsch, R. Kelley, Weiru Wang, 2013, Clinical Cancer Research.

Cancer Therapy : Preclinical Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL 12

M. Ultsch, R. Kelley, Weiru Wang, 2013 .